Daily Vibrotactile Stimulation Exhibits Equal or Greater Spasticity Relief Than Botulinum Toxin in Stroke.

ABSTRACT:

Objective

To test the feasibility and efficacy of the VibroTactile Stimulation (VTS) Glove, a wearable device that provides VTS to the impaired limb to reduce spastic hypertonia.

Design

Prospective 2-arm intervention study-including 1 group of patients who use Botulinum toxin (BTX-A) for spasticity and 1 group of patients who do not use BTX-A.

Setting

Participants were recruited through rehabilitation and neurology clinics.

Participants

Patients with chronic stroke (N=20; mean age=54 years, mean time since stroke=6.9 years). Patients who were previously receiving the standard of care (BTX-A injection) were eligible to participate and started the intervention 12 weeks after their last injection.

Intervention

Participants were instructed to use the VTS Glo

SUBMITTER: Seim C 

PROVIDER: S-EPMC11326884 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature